Lipoprotein(a) increase associated with thyroid autoimmunity

European Journal of Endocrinology

Volumn 136, Issue 1, 1997, Pages 87-91

  Lotz, Helga ^a   Salabè, Giovanni B ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; LIPOPROTEIN A; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; THYROIDITIS; THYROTROPIN BLOOD LEVEL;

EID: 0031040719     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360087     Document Type: Article

References (29)

1. Utermann G. The mysteries of lipoprotein(a). Science 1989 246 904-910.
2. McLean JW, Tomlinson JT, Kuang WJ, Eaton DL, Chen EY, Fless GM et al. cDNA sequence of apolipoprotein(a) is homologous to plasminogen. Nature 1987 300 132-137.
3. Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W & Morrisett JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). Journal of Lipid Research 1990 31 603-613.
4. Hong Y, Dahlen GH, Pedersen N, Heller AH, McClearn GE & de Faire U. Potential environmental effects on adult lipoprotein(a) levels: results from Swedish twins. Atherosclerosis 1995 117 295-304.
5. Soma M, Fumagalli R, Paoletti R, Meschia M, Maini MC, Crosignani P, Ghanem K, Gaubatz J & Morrisett J. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 1991 337 612.
6. Hiraga T, Harada K, Kobayashi T & Murase T. Reduction of serum Lp(a) using estrogen in a man with familial hypercholesterolemia. Journal of the American Medical Association 1992 267 2338-2339.
7. Klausen C, Nielsen FE, Hegedüs L, Gerdes LU, Charles P & Faergeman O. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a). Metabolism 1992 41 911-914.
8. De Bruin TWA, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ & Erkelens DW. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. Journal of Clinical Endocrinology and Metabolism 1993 76 121-126.
9. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clarke F et al. The spectrum of thyroid disease in a community: the Wickham survey. Clinical Endocrinology 1977 7 481-493.
10. Salabè GB, Salabè-Lotz H, Menotti A, Muntoni S, Descovich G, Antonini R et al. Thyroid autoimmunity in five samples of general population in Italy. In Autoimmunity and the Thyroid, pp 551-553. Eds A Pinchera, S Ingbar, JM McKenzie & GF Fenzi. New York: Academic Press Inc, 1987.
11. Scanu AM. Lipoprotein(a). A genetic risk factor for premature coronary heart disease. Journal of the American Medical Association 1992 267 3326-3329.
12. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994 108 111-126.
13. Plow EF, Herren T, Redlitz A, Miles LA & Hoover-Plow JL. The cell biology of the plasminogen system. FASCB Journal 1995 9 939-945.
14. Bastenie PA, Vanhaelst L & Nève P. Coronary-artery disease in hypothyroidism: observations in preclinical myxoedema. Lancet 1967 II 1221-1222.
15. Bastenie PA, Golstein J, Vanhaelst L, Smets PH, Keys A, Karvonen MJ et al. Asymptomatic autoimmune thyroiditis and coronary heart disease. Lancet 1977 2 155-158.
16. Salabè GB, Salabè-Lotz H, Puletti M & Milani C. Hypothyroidism and thyroid autoimmunity in acute myocardial infarction. Thyroidology Clinical and Experimental 1989 1 67-72.
17. Biancalana MM. Romaldini JH, Farah CS, Figueiredo DI, Rassi I, Arma-ganijan D et al. Elevated serum levels of antibodies against thyroglobulin (TgAb) and thyroid peroxidase (TPOAb) in patients with myocardial infarction: is it a risk factor? Thyroid 1995 5 Suppl 1 179.
18. Salabè GB, Salabè H, Dominici R, Davoli C & Andreoli M. Radioimmuno-assay for human antithyroglobulin antibodies. II Determination of antigen binding capacity. Journal of Clinical Endocrinology and Metabolism 1974 39 1125-1132.
19. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G & Boer-winkle E. Defects in the low density lipoprotein receptor gene affect lipoprotein(a): multiplicative interaction of two gene loci associated with premature atherosclerosis. Proceedings of the National Academy of Sciences of the USA 1989: 86 4171-4174.
20. Bartens W, Rader DJ, Talley G & Brewer BJ Jr. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Atherosclerosis 1994 108 149-157.
21. Heinrich J, Sandkamp M, Kokott R, Schulte H & Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clinical Chemistry 1991 37 1950-1954.
22. Slunga L, Asplund K, Johnson O & Dahlen GH. Lipoprotein(a) in a randomly selected 25-64 year old population: the Northern Sweden MONICA study. Journal of Clinical Epidemiology 1993 46 617-624.
23. Schram JHN, Boerrigter PJ & The TY. Influence of two hormone replacement therapy regimes, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dihydrogesterone, on lipid metabolism. Maturitas 1995 22 121-130.
24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 801-809.
25. Reblin T, Meyer N, Labeur C, Henne-Bruns D & Beisiegel B. Extraction of lipoprotein(a), apoB, and apoE from fresh human arterial wall and athero-sclerotic plaques. Atherosclerosis 1995 113 179-188.
26. Sarria A, Moreno LA, Mur M, Lazaro A, Lasierra MP, Roda L et al. Lymphocyte T subset counts in children with elevated low-density lipoprotein cholesterol levels. Atherosclerosis 1995 117 119-123.
27. Rantapää-Dahlquist S, Wallberg-Jonsson S & Dahlen GH. Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 1991 50 366-368.
28. Kapelrud H, Bangstad HJ, Dahl-Jorgensen K, Berg K & Haussen KP. Serum Lp(a) lipoprotein concentration in insulin dependent diabetic patients with microalbuminuria. British Medical Journal 1991 303 675-678.
29. Dahlen G, Boman J, Birgander LS & Lindblom B. Lp(a) lipoprotein. IgG, IgA and IgM antibodies to Chlamidia pnewnoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995 114 165-174.